PDCD1 and non-small cell lung carcinoma: A study examining peripheral blood samples from patients with advanced non-small-cell lung cancer receiving PD-1-targeted therapy reported that most patients exhibited an increase in the number of PD-1+CD8+ T cells after treatment and that this increase was correlated with treatment benefits (183).